Abstract
The present article highlights diverse roles of stem cells in healthy state, oncology and regenerative medicine in comparison to the Clear Cell Renal Cell Carcinoma (ccRCC) “stem cells”. Furthermore, we support the notion of urgent need to change the terminology of “cancer stem cells” into tumor-propagating cells (TPCs), and to diversify terms of kidney stem and kidney progenitor cell. We present the role of normal stem and progenitor cells in kidney development and regeneration in comparison to their markers. Moreover, we would like to introduce a hypothesis about the TPCs origin, and the role epithelial to mesenchymal transition in metastasis. We described current knowledge about various approaches to identification of renal TPCs. Finally, we present future perspectives in respect to current studies.
Keywords: Cancer stem cells, ccRCC, stem cells, tumor-propagating cells.
Current Signal Transduction Therapy
Title:Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Volume: 8 Issue: 3
Author(s): Damian Matak, Lukasz Szymanski, Anna Czarnecka, Ewa Bartnik and Cezary Szczylik
Affiliation:
Keywords: Cancer stem cells, ccRCC, stem cells, tumor-propagating cells.
Abstract: The present article highlights diverse roles of stem cells in healthy state, oncology and regenerative medicine in comparison to the Clear Cell Renal Cell Carcinoma (ccRCC) “stem cells”. Furthermore, we support the notion of urgent need to change the terminology of “cancer stem cells” into tumor-propagating cells (TPCs), and to diversify terms of kidney stem and kidney progenitor cell. We present the role of normal stem and progenitor cells in kidney development and regeneration in comparison to their markers. Moreover, we would like to introduce a hypothesis about the TPCs origin, and the role epithelial to mesenchymal transition in metastasis. We described current knowledge about various approaches to identification of renal TPCs. Finally, we present future perspectives in respect to current studies.
Export Options
About this article
Cite this article as:
Matak Damian, Szymanski Lukasz, Czarnecka Anna, Bartnik Ewa and Szczylik Cezary, Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics, Current Signal Transduction Therapy 2013; 8 (3) . https://dx.doi.org/10.2174/1574362409666140206222607
DOI https://dx.doi.org/10.2174/1574362409666140206222607 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Approaches for the Treatment with Thyroid Hormone Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer
Current Drug Targets Notch-Associated MicroRNAs in Cancer
Current Drug Targets Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Current Medicinal Chemistry Application of Targeted Therapy to Malignant Gliomas and Response to Treatment
Current Signal Transduction Therapy Protein Transduction Domains: Applications for Molecular Medicine
Current Gene Therapy dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention
Current Protein & Peptide Science The Contrasting Roles of NKT Cells in Tumor Immunity
Current Molecular Medicine Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases
Central Nervous System Agents in Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives
Current Medicinal Chemistry Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
Current Pharmaceutical Design Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Current Vascular Pharmacology Celecoxib and Dimethylcelecoxib Block Oxidative Phosphorylation, Epithelial-Mesenchymal Transition and Invasiveness in Breast Cancer Stem Cells
Current Medicinal Chemistry Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry